Content area

|
|

Behandling af synstruende diabetisk retinopati

Forfatter(e)

Jakob Grauslund1, 2

1) Øjenafdeling E, Odense Universitetshospital 2) Forskningsenheden for Oftalmologi, Klinisk Institut, Syddansk Universitet Ugeskr Læger 2018;180:V11170870

Reference: 
Ugeskr Læger 2018;180:V11170870
Blad nummer: 
Sidetal: 
2-5
Treatment of sight-threatening diabetic retinopathy

In diabetic retinopathy, treatment is indicated for sight-threatening complications like proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DME). For decades, treatment has been with panretinal laser for PDR and focal/grid laser for DME. In recent years, intravitreal therapy with vascular endothelial growth factor (VEGF) inhibition or steroids has replaced laser treatment in centre-involving DME. Intravitreal VEGF-inhibition has also demonstrated effectiveness in PDR, but long-term studies are needed to address the concern of a potential continuous treatment burden.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Torben Albert Devantier | 21/02
2 kommentarer
af Turid Eva Klaveness Hansen | 21/02
1 Kommentar
af Dorte Lander Rasmussen | 21/02
1 Kommentar
af Gert Frank Thomsen | 17/02
1 Kommentar
af Kaare Rossel | 17/02
1 Kommentar
af Niels Rokkjær | 16/02
1 Kommentar
af Niels Egund | 15/02
2 kommentarer
af Astrid Hanna M. Schulze | 14/02
1 Kommentar